ZAGREB, March 28 (Hina) - The response of foreign investors to
purchase shares of the Croatian pharmaceutical company "Pliva" was
beyond all expectations, Zagrebacka Banka said in a statement on
Thursday.
The most respectable and best international investors and
banks had shown an interest in Pliva's shares which largely
exceeded the supply, the statement said.
The price of Pliva's shares was set in London on Thursday,
with one share being sold at 5,100 kuna or DM 1,378.
The value of Pliva's shares was expected to grow with trading
on the secondary market, scheduled to begin on April 11.
This was the first Croatian company whose shares were verified
by the international capital market.
Zagrebacka Banka said it had decided to extend a bid for
purchase of Pliva's shares on the domestic market for another three
days, until March 30.
(hina) vm jn
281851 MET mar 96
EK će tolerirati veće deficite ako članice troše na obranu
Najava događaja - fotografije - za utorak, 4. veljače
Najava događaja - sport - za utorak, 4. veljače
Najava događaja - kultura - za utorak, 4. veljače
Najava - gospodarstvo - za utorak, 4. veljače
Najava događaja - svijet - za utorak, 4. veljače
Najava događaja - Hrvatska - za utorak, 4. veljače
Španjolska policija pronašla tijelo Hrvata za kojim se tragalo
Trudeau: SAD na mjesec dana odgađa uvođenje carina Kanadi
SP, dvoranski hokej: Porazi hrvatskih reprezentacija